Prollenium Medical Technologies (“Prollenium” or the “Company”) announced today that Ario Khoshbin is stepping down as Chief Executive Officer to focus on his role as a member of Prollenium’s Board of Directors. Ario remains a significant shareholder of Prollenium. “Welcoming a CEO with new expertise and perspective will allow Prollenium to continue to achieve its potential as one of the world’s leading global developers and manufacturers of aesthetic products,” said Justin Bateman, Chair of P...

Building on the progress of the first two rounds, the Center for Disease Analysis Foundation (CDAF) Relink program is pleased to announce seven hundred and eighty-two thousand dollars in funding for its third round of grantees. The following six organizations are beneficiaries: Organization Organization Type State Bluestone Health Association Inc. Healthcare Institution WV Carilion Clinic Healthcare Institution VA Cooperman Barnabas Medical Center...